← American Pharmacists Association (APhA)
FDANonrulemakingFDA-2017-N-2903

Data and Methods for Evaluating the Impact of Opioid Formulations with Properties Designed to Deter Abuse in the Postmarket Setting: A Scientific Discussion of Present and Future Capabilities; Public Workshop; Issues Paper; Request for Comments

RIN
—
Last modified
Sep 15, 2017
Comment window
closed 3242d ago
American Pharmacists Association (APhA) filings
1

Activity

American Pharmacists Association (APhA) filed 1 comment on this docket between Sep 12, 2017 and Sep 12, 2017. 1 other organizations filed here. The comment window closed 3242d ago.

What American Pharmacists Association (APhA) filed (1)

Sep 12, 2017· Comment from American Pharmacists Association (APhA)· FDA-2017-N-2903-0011

Please see attached for comments from the American Pharmacists Association.

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (1)

See everyone who commented →